Core Viewpoint - Fulejia, a leading domestic beauty brand, reported a significant decline in revenue and profit for the first half of 2025, indicating ongoing challenges in the market despite previous growth [1][4][27]. Financial Performance - Revenue decreased by 8.15%, from 9.40 billion to 8.63 billion yuan [2][3]. - Net profit dropped by 32.54% to 2.30 billion yuan, while net profit excluding non-recurring items fell by 48.66% to 1.66 billion yuan [2][3]. - Operating cash flow also declined by 54.69% [2][3]. Product Segmentation - The revenue from medical device products was 2.38 billion yuan, accounting for 27.61% of total revenue, down 48.07% year-on-year [6][9]. - Cosmetic products generated 6.25 billion yuan, representing 72.39% of total revenue, with a year-on-year growth of 29.95% [6][9]. - Gross margins for both product categories exceeded 80%, with medical devices increasing by 2.93% to 84.22% and cosmetics decreasing by 1.11% to 80.42% [3][6]. Sales Channels - Online sales accounted for over 80% of total revenue, growing by 47.11% to 6.95 billion yuan, while offline sales plummeted by nearly 64% to 1.68 billion yuan [16][19]. - The shift towards online sales reflects a broader trend, with online sales surpassing 50% for the first time in 2024 [19]. Marketing and R&D Investment - Sales expenses surged by 39.56% to 4.20 billion yuan, constituting 48.67% of revenue, primarily due to increased promotional activities [21][22]. - R&D investment rose by 47.65% to 23.33 million yuan, representing 2.7% of revenue, with a total of 69 R&D personnel, an increase of 18.97% [23][25]. Market Outlook - The skin care product market in China is projected to reach 518.5 billion yuan by 2026, with functional skin care and medical dressing products expected to grow significantly [26][27]. - Despite current challenges, the market's growth potential offers Fulejia opportunities to reverse its declining performance [27].